Analyst Ratings for Regeneron Pharma (regn) [Buys]
regn Rating Summary
regn Price Target Summary
- Highest: $1,189.00 (RBC Capital)
- Lowest: $720.00 (BofA Securities)
- Average: $1,028.53
* Over Last 12-Mos
Overall Rating:
BUY
Rating Trend:
Avg. $ Target:
$1,028.53 (+14.7%)
* Over Last 12-Mos
Rating Score: 6.7 / 10
Percentile Rank: 72%
Avg. $ Target:
$1,028.53 (+14.7%)
* Over Last 12-Mos
Rating Score: 6.7 / 10
Percentile Rank: 72%
| Date | Firm | Analyst | Type | Rating (Past) |
PT (Past) |
Start $ (End $) |
% Chg. | Details |
|---|---|---|---|---|---|---|---|---|
| 3/12/2024 | Bernstein SocGen Group | William Pickering | New Coverage | Outperform (N/A) |
1,125.00 (N/A) |
968.83 (896.82) |
-7.43% | Details |
| 1/12/2024 | RBC Capital » Updated 4/11/2024 |
Brian Abrahams | Upgrade | Outperform (Sector Perform) |
1,189.00 (N/A) |
915.97 (896.82) |
-2.09% | Details |
 |
||||||||
|
||||||||
|
||||||||
|
||||||||
|
||||||||
|
||||||||
|
||||||||
|
||||||||
